• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION 2.5/18; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION 2.5/18; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 419120
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 09/25/2021
Event Type  Injury  
Manufacturer Narrative
Combination product: yes.
 
Event Description
An orsiro mission drug-eluting stent system was selected for treatment in context of the dapt-study.A late stent thrombosis was reported in the distal rca.Patient experienced stemi and was admitted to the hospital.Angiography showed a stent thrombosis in the target lesion.Revascularization of target lesion, implantation of an additional orsiro mission stent and medication therapy was performed with good outcome.
 
Manufacturer Narrative
Combination product: yes.After the successful index procedure of two distal rca lesions, the patient developed a late stent thrombosis (107d) with confirmed inferior stemi.The affected device was not returned and could therefore not be subjected to a technical investigation.The review of the index angiographic images revealed severe stenosis of two distal rca segments treated successfully by des placement.Further, the review of the ae angiographic images confirmed the reported flow-limiting st in the distal rca, which was treated with des placement.However, a review of the product release documentation confirmed that the device was manufactured according to specifications and fulfilled all the in-process and final inspection requirements.Based on the provided documentation, no device deficiency or manufacturing-related root cause could be identified.The clinical event committee event adjudicated the case as spontaneous mi with late st due to clinical reasons.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO MISSION 2.5/18
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
Manufacturer Contact
6024 jean road
lake oswego, OR 97035
8772459800
MDR Report Key12631212
MDR Text Key276349280
Report Number1028232-2021-05691
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/14/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/11/2022
Device Model Number419120
Device Catalogue NumberSEE MODEL NO.
Device Lot Number10203125
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/26/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/11/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-